Michael R. Foley - 28 Jan 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
Chief Medical Officer
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Issuer symbol
SERA
Transactions as of
28 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 17:06:55 UTC
Previous filing
04 Jan 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Award $0 +276,000 $0.000000 276,000 28 Jan 2022 Class A Common Stock 276,000 $6.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is January 28, 2022, and 1/36 of the remaining amount vests in monthly installments for three years thereafter.